Sovah Health - Danville, previously known as Danville Regional Medical Center is a 250-bed hospital located in Danville, Virginia, US. It was formerly known as The Memorial Hospital and changed its name in 1993, before being purchased by Lifepoint Hospitals in July 2005.

There are 250 beds in Danville Regional Medical Center.

During the past decade, Danville Regional Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 89 clinical trials were completed, i.e. on average, 809.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 15 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Danville Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "SWOG Cancer Research Network" with 39 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "Radiation Therapy Oncology Group" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Danville Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 95 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Danville Regional Medical Center" are "Lung Cancer" (16 trials), "Lymphoma" (12 trials), "Breast Cancer" (11 trials), "Prostate Cancer" (10 trials) and "Recurrent Breast Carcinoma" (8 trials). Many other conditions were trialed in "Danville Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Danville Regional Medical Center" are "Drug" (125 trials), "Other" (70 trials), "Biological" (58 trials), "Radiation" (30 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "radiation therapy" (16 trials), "Bevacizumab" (14 trials), "Paclitaxel" (14 trials) and "Quality-of-Life Assessment" (14 trials). Other intervention names were less common.

The vast majority of trials in "Danville Regional Medical Center" are 122 trials for "All" genders, 23 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Danville Regional Medical Center". undefined are not yet recruiting, 2 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 99 completed trials in Danville Regional Medical Center, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Danville Regional Medical Center, 7 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".